A Randomized Controlled Trial to Evaluate the Safety and Efficacy of an Oral Supplement in Supporting Vision and Eye Health
NCT ID: NCT07123584
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-11-06
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Trial to Evaluate the Efficacy of an Oral Supplement in Supporting Vision and Eye Health
NCT06515457
Efficacy and Safety Safety of Nutritears® in Adults With Dry Eye Syndrome
NCT05481450
Dry Eye Symptom Mitigation by Oral Intake of Probiotics
NCT05906381
Efficacy of Twinkle Eyez Supplementation in Improving Ocular Health and Immunity
NCT06574685
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry Eye
NCT00883649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Eye Empower supplement
Eye Empower
A multi-ingredient oral supplement formulated to support eye health. Daily dose (3 capsules).
Placebo
Placebo
Identical gelatin capsules filled with inert rice flour, administered in the same dosage (3 capsules daily).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye Empower
A multi-ingredient oral supplement formulated to support eye health. Daily dose (3 capsules).
Placebo
Identical gelatin capsules filled with inert rice flour, administered in the same dosage (3 capsules daily).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 45 or over
* Self-reported concerns about all three of the following symptoms over the last 4 weeks:
Dry eyes, Irritated eyes, Eye fatigue
\- Self-reported concerns about any of the following symptoms over the last 4 weeks: Sensitivity to blue light, Blurred vision, far or near, Red or itchy eyes, Eye inflammation
* Generally healthy - do not live with any uncontrolled chronic diseases
* Willing to avoid using any new prescriptions, over-the-counter medications, supplements, and herbal remedies for the study that target eye health. This includes the use of new prescription eyeglasses or sunglasses
* If taking oral over-the-counter supplements or herbal remedies targeted at eye health, has been consistently taking these for at least 3 months prior to starting the study, and is willing to maintain this routine for the study duration
* Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
Exclusion Criteria
* Anyone with diagnosed diabetes (Type I or Type II)
* Planning to undergo any procedure related to their eye health during the study
* Planning to undergo any surgeries or invasive treatments for the study duration
* Has undergone any surgeries or invasive treatments in the last six months
* History of any major illness in the last three months
* Anyone currently taking or has taken a supplement with one or more of the active ingredients in the test product in the last month (e.g., turmeric)
* Started any new medications or supplements that target eye health in the past 3 months
* Anyone with known severe allergic reactions that may require the use of an EpiPen, including but not limited to a shellfish or a latex allergy
* Women who are pregnant, breastfeeding, or trying to conceive currently and for the duration of the study
* Anyone on a medication or herbal supplement that can impact the blood (e.g., blood thinner, anticoagulant, etc.) including but not limited to:
Coumadin (Warfarin) Aspirin Plavix (Clopidogrel)
* Anyone who does not consume animal products for religious and/or personal reasons
* Unwilling to follow the study protocol
* Anyone who has undergone any surgeries or invasive treatments in the last three months or has any planned during the study period
* Anyone with a history of substance abuse
* Anyone who uses illicit drugs, including cannabis
* Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men)
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Citruslabs
INDUSTRY
Bio Nature Health
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Citruslabs
Las Vegas, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20686
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.